NLRP3 inflammasomes link inflammation and metabolic disease

De Nardo, Dominic, Latz, Eicke·2011·Trends in Immunology
DOI 10.1016/j.it.2011.05.004

Cited by (431)

Items 301–400 of 431

  1. Increased incidence of non‐alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis
    Nicole E. De Long, Daniel Barry Hardy, Noelle Ma, Alison C. Holloway · 2017 · Journal of Applied Toxicology
  2. Proinflammatory profile of visceral adipose tissue and oxidative stress in severe obese patients carrying the variant rs4612666 C of NLRP3 gene
    Anna Perri, Danilo Lofaro, Antonella La Russa, Simona Lupinacci, Giuseppina Toteda, Achiropita Curti, Antonino Urso, Renzo Bonofiglio, Daniele La Russa, Daniela Pellegrino et al. · 2021 · Minerva Endocrinology
  3. NACHT, LRR and PYD domains-containing protein 3 inflammasome is activated and inhibited by berberine via toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-κB pathway, in phorbol 12-myristate 13-acetate-induced macrophages
    Zhouqing Huang, Bozhi Ye, Jibo Han, Fanqi Kong, Peiren Shan, Zhongqiu Lu, Zhouqing Huang, Weijian Huang · 2017 · Molecular Medicine Reports
  4. Leptin Signaling in the Ovary of Diet-Induced Obese Mice Regulates Activation of NOD-Like Receptor Protein 3 Inflammasome
    Marek Adamowski, Karolina Wołodko, Joana Oliveira, Juan Castillo Fernandez, Daniel Murta, Gavin Kelsey, António Miguel Galvão · 2021 · Frontiers in Cell and Developmental Biology
  5. Instant membrane resealing in nlrp3 inflammmasome activation of endothelial cells
    Pin‐Lan Li · 2015 · Frontiers in bioscience
  6. Freshwater Clam Extract Inhibits Inflammatory Responses in LPS-Activated Macrophages by Reducing the Activation of Mitogen-Activated Protein Kinases and NF-κB
    Kuo‐Feng Hua, Guan-Ming Chen, Chen‐Lung Ho, Ming-Chung Chen, Yi‐Lin Sophia Chen, Wei‐Jung Chen, Jeng-Fang Huang, Yuan‐Shing Perng, Chai-Ching Lin · 2012 · Natural Product Communications
  7. NPC Natural Product Communications
    Shabana I. Khana, John P. Hester, Babu L. Tekwania, Jacob O. Midiwob, Ilias Muhammada, Surendra K. Jaina, Melissa R. Jacoba, Larry A. Walkera, Aziz A. Rahmana, Volodymyr Samoylenkoa · 2011
  8. C1q/tumour necrosis factor-related protein-3 alleviates high-glucose-induced lipid accumulation and necroinflammation in renal tubular cells by activating the adenosine monophosphate-activated protein kinase pathway
    Chunyang Du, Yan Zhu, Yan Yang, Lin Mu, Xue Yan, Ming Ting Wu, Chenming Zhou, Haijiang Wu, Wei Zhang, Yanhui Wu et al. · 2022 · The International Journal of Biochemistry & Cell Biology
  9. The Role of NLRP3 Inflammasome in Oral Squamous Cell Carcinoma
    Rui Shi, Xuan Zhuang, Ying Liu, Song-nan Yao, Feng-shan Xue · 2025 · Journal of Inflammation Research
  10. The use of SGLT2 inhibitors in older people: What is important?
    Giuseppe Armentaro, Raffaele Maio, Leonardo Bencivenga, Chukwuma Okoye, Giandomenico Severini, Velia Cassano, Valeria Zanobbi, Valentino Condoleo, Giuseppe Bellelli, Giuseppe Rengo et al. · 2025 · Aging Clinical and Experimental Research
  11. Noncoding RNAs: Versatile regulators of endothelial dysfunction
    Xiong Piao, Lie Ma, Qinqi Xu, Xiaomin Zhang, Jin Cheng-zhu · 2023 · Life Sciences
  12. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol
    Kiyoshi Migita, Yoshika Tsuji, Keiko Hisatomi, Riyoko Shigeno, Yasumori Izumi, Nozomi Iwanaga, Tomohiro Koga · 2015 · Modern Rheumatology
  13. Targeting NLRP3 inflammasome via acetylsalicylic acid: Role in suppressing hepatic dysfunction and insulin resistance induced by atorvastatin in naïve versus alcoholic liver in rats
    Omnyah Ali El-Kharashi, Dalia Alaa El-Din Aly El-Waseef, Enas Samir Nabih, Doaa I. Mohamed · 2018 · Biomedicine & Pharmacotherapy
  14. Povidone iodine suppresses LPS-induced inflammation by inhibiting TLR4/MyD88 formation in airway epithelial cells
    Seung Hoon Lee, Mi‐Ra Choi, Jaein Chung, Seung-Hyeon Choi, Soo Kyoung Park, Yong Min Kim · 2022 · Scientific Reports
  15. Endothelial nlrp3 inflammasome activation associated with lysosomal destabilization during coronary arteritis (851.5)
    Yang Chen, Krishna Murthy Boini, Ashley L. Pitzer, Yang Zhang, Pin‐Lan Li · 2014 · The FASEB Journal
  16. NLRP3 inflammasome activation in PCOS: A novel target for managing insulin resistance and metabolic dysregulation
    Fatemeh Samadi, Hanie Babei, Mehrnaz Nayebzadeh, Elahe Sadati, Ziba Zahiri, Tayebeh Esfidani, Shabnam Forouzin, Atoosa Etezadi · 2025 · Tissue and Cell
  17. NLRP3 sparks the Greek fire in the war against lipid‐related diseases
    Shuai Jiang, Haoxiang Xiao, Zhen Biao Wu, Zhi Ping Yang, Baoping Ding, Zhenxiao Jin, Yang Yang · 2020 · Obesity Reviews
  18. The study of routine laboratory factors in children with mycoplasma pneumoniae pneumonia: serum uric acid may have anti‐inflammatory effect
    Chenglin Pan, Yanjie Chen, Shaosheng Wang, Ming Li, Shen Qu · 2021 · Journal of Clinical Laboratory Analysis
  19. Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation
    Laura González‐Cofrade, Sandra Oramas‐Royo, Irene Cuadrado, Ángel Amesty, Sonsoles Hortelano, Ana Estévez‐Braun, Beatriz de las Heras · 2020 · Journal of Natural Products
  20. FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights
    Teresa Krakauer · 2017 · ImmunoTargets and Therapy
  21. Celastrol ameliorates fibrosis in Western diet/tetrachloromethane-induced nonalcoholic steatohepatitis by suppressing Notch/osteopontin signaling
    Dingwu Li, Jianing Chen, Chenhui Ye, Bingru Lin, Tiantian Zhang, Qingxia Chen, Chaohui Yu, Xingyong Wan · 2025 · Phytomedicine
  22. Interleukin‐1 Signaling on Vascular Smooth Muscle Cells Accelerates Atherosclerosis in a Murine Model of Kawasaki Disease
    Shuang Chen, Asli Savas, Asli E. Atici, Youngho Lee, Malcolm E. Lane, Emily A. Aubuchon, Debbie Moreira, Alexander Hsu‐Wilbraham, Kenichi Shimada, Timothy R. Crother et al. · 2025 · Journal of the American Heart Association
  23. Acid Sphingomyelinase and Ceramide Signaling Pathway Mediates Nicotine-Induced NLRP3 Inflammasome Activation and Podocyte Injury
    Mohammad Atiqur Rahman, Sayantap Datta, Harini Lakkakula, Saisudha Koka, Krishna Murthy Boini · 2025 · Biomedicines
  24. Immune System, Gut Microbiota and Diet: An Interesting and Emerging Trialogue
    Marianna Roselli, Raffaella Canali, Alberto Finamore, Andrea Ghiselli, Chiara Devirgiliis · 2022 · IntechOpen eBooks
  25. Insights into radiation carcinogenesis based on dose-rate effects in tissue stem cells
    Kensuke Otsuka, Toshiyasu Iwasaki · 2023 · International Journal of Radiation Biology
  26. Inflammatory Effects of the Plant Protection Product Stifenia (FEN560) on Vertebrates
    Lény Teyssier, J. Colussi, Stéphanie Delemasure, Johanna Chluba, David Wendehenne, Olivier Lamotte, Jean‐Louis Connat · 2017 · Frontiers in Public Health
  27. The integrin CD11b inhibits MSU-induced NLRP3 inflammasome activation in macrophages and protects mice against MSU-induced joint inflammation
    Driss Ehirchiou, Ilaria Bernabei, Vishnuprabu Durairaj Pandian, Sonia Nasi, Véronique Chobaz, Mariela Castelblanco, Alexander K. L. So, Fabio Martinon, Xiaoyun Li, Hans Acha‐Orbea et al. · 2024 · Arthritis Research & Therapy
  28. Inulin and Lycium barbarum polysaccharides mitigate the diabetic inflammatory response by modulating bile acid metabolism to enhance regulatory T cell (Treg) activation in a rat model of diabetes
    Haixia Lü, Hongyan Luo, Peiling Li, Yan Yang, Shilu Cao, Yanfang Zhang, Hongxia Ma, Qian Zhao, Yali Zheng, Hao Wang · 2025 · Frontiers in Endocrinology
  29. Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies
    Shubham Upadhayay · 2026 · International Immunopharmacology
  30. Cell death induced by NLRP3 –palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity‐tuberculosis comorbidity
    Sandra Patricia Palma Albornoz, Thais Fernanda de Campos Fraga‐Silva, Robson Amparo de Carvalho, Tamara Silva Rodrigues, Ana Flávia Gembre, Rômulo Silva de Oliveira, Fernanda Mesquita de Souza, Giseli Furlan Corrêa, Leandra Náira Zambelli Ramalho, Daniela Carlos et al. · 2022 · The Journal of Pathology
  31. Empagliflozin in diabetic cardiomyopathy: elucidating mechanisms, therapeutic potentials, and future directions
    Aiswarya Jaiswal, Poonam Yadav, Pushkar Singh Rawat, Maninder Kaur, Srivalliputturu Sarath Babu, Amit Khurana, Jasvinder Singh Bhatti, Umashanker Navik · 2025 · Molecular Biology Reports
  32. The Relationship Between Caspase-1 Related Inflammasomes Expression and Serum Inflammatory Cytokines Levels During Acute Brucellosis.
    Gamze Karaca · 2018 · Northern Clinics of Istanbul
  33. rs3806265 and rs4612666 of the NLRP3 Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes
    Xiaoxiao Sun, Linling Xu, Ying Xia, Shuoming Luo, Jian Lin, Yang Xiao, Gan Huang, Xia Li, Zhiguo Xie, Zhiguang Zhou · 2022 · Frontiers in Endocrinology
  34. New potential therapeutic targets of metabolic disorder–associated kidney disease and diabetic kidney disease
    Xuezhu Li, Cijiang He, Kyung Lee · 2025 · Kidney International
  35. Flavonoid-Conjugated Gadolinium Complexes as Anti-Inflammatory Theranostic Agents
    Byeong Woo Yang, So-Hyeon Yang, Soyeon Kim, Ahrum Baek, Bokyung Sung, Yeoun‐Hee Kim, Jung Tae Lee, Sang Yun Lee, Hee‐Kyung Kim, Garam Choi et al. · 2022 · Antioxidants
  36. Coronary atherosclerosis: Significance of autophagic armour
    Mansi Arora · 2012 · World Journal of Cardiology
  37. Pattern recognition receptors as potential therapeutic targets in metabolic syndrome: From bench to bedside
    Amanda Almeida de Oliveira, Destiny Davis, Kênia Pedrosa Nunes · 2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  38. Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study
    Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H. Wild, Christopher D. Byrne · 2024 · Diabetes Obesity and Metabolism
  39. Reconstituting the NLRP1 Inflammasome In Vitro
    Benjamin Faustin, John C. Reed · 2013 · Methods in molecular biology
  40. Early detection and progression of insulin resistance revealed by impaired organismal anti-inflammatory heat shock response during ex vivo whole-blood heat challenge
    Helena Trevisan Schroeder, Carlos Henrique de Lemos Muller, Maria Inês Lavina Rodrigues, Marcela Alves de Azevedo, Thiago Gomes Heck, Maurício da Silva Krause, Paulo Ivo Homem de Bittencourt · 2024 · Clinical Science
  41. Association of Genetic, Environmental, and Nutritional Factors With Metabolic Phenotypes of Obesity: A Scoping Review
    Haniyeh Danesh Doost, Milad Nasiri Jounaghani, Roya Riahi, M. Heidari-Beni, M. Hosseini, F. Sharifianjazi, Roya Kelishadi · 2025 · Journal of Obesity
  42. CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration
    Luis Jaramillo‐Valverde, Kelly S. Levano, Silvia Capristano, David D. Tarazona, Alberto Cisneros, Velia M. Yufra‐Picardo, Julio Valdivia‐Silva, Heinner Guio · 2021 · Cureus
  43. Astragaloside IV plays a role in reducing radiation-induced liver inflammation in mice by inhibiting thioredoxin-interacting protein/nod-like receptor protein 3 signaling pathway.
    Ding Yanping, Xiaoqing Dong, M A Yifan, Chen Lili, Zhou Jie, L I Xinyan, Shao Baoping · 2023 · PubMed Central
  44. Expression of innate immunity genes in human hematopoietic stem/progenitor cells – single cell RNA-seq analysis
    Justyna Jarczak, Kannathasan Thetchinamoorthy, Diana Wierzbicka, Kamila Bujko, Mariusz Z. Ratajczak, Magda Kucia · 2025 · Frontiers in Immunology
  45. Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
    Qin Zhang, Ming Yang, Ying Xiao, Yachun Han, Shikun Yang, Lin Sun · 2019 · Current Medicinal Chemistry
  46. Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats.
    Jacqueline C. Silva, Margherita Bavestrello, Valerio Gazzola, Giovanni Spinella, Bianca Pane, Elena Grasselli, Ilaria Demori, Laura Canesi, Laura Emionite, Michele Cilli et al. · 2022 · Life Sciences
  47. Effects of intestinal lymphatic ligation on intestinal immunity in rats with severe acute pancreatitis
    Yuanqi Liu, Li Chen, Lulu Wang, Yuxia Xiong · 2021 · FEBS Open Bio
  48. Atherosclerosis
    Elena Luk, A I Gotlieb · 2014 · Elsevier eBooks
  49. El inflamasoma: mecanismos de activación.
    Raibel Suárez, Neudo Buelvas · 2015 · Redalyc (Universidad Autónoma del Estado de México)
  50. Role of the Immune System in Obesity-Associated Inflammation and Insulin Resistance
    Yoshinori Nagai, Kiyoshi Takatsu · 2014 · Elsevier eBooks
  51. Q969R polymorphism in NLRP 3 is associated with immune responses to vaccination against bacterial infections in pigs
    Hiroki Shinkai, Kei Terada, Daisuke Toki, Masanori Tohno, Hirohide Uenishi · 2018 · Animal Science Journal
  52. Nanogenetics in diabetes: converging nanoscale platforms and gene modulation for metabolic reprogramming
    Ruchı Tıwarı, Patibandla Jahnavi, Gurinderdeep Singh, Piyali Dey, Farhad F. Mehta, Tirthankar Choudhury, Kamal YT, Arvind Kumar Bhandari, Pankaj Sharma · 2025 · Journal of Biomaterials Science Polymer Edition
  53. Anti-inflammatory effects of N-cyclooctyl-5-methylthiazol-2-amine hydrobromide on lipopolysaccharide-induced inflammatory response through attenuation of NLRP3 activation in microglial cells
    Eun‐A Kim, Kyouk Hwang, Ji‐Eun Kim, Jee‐Yin Ahn, Soo Young Choi, Seung-Ju Yang, Sung‐Woo Cho · 2021 · BMB Reports
  54. Examining the Effect of Consuming C 8 Medium‐Chain Triglyceride Oil for 14 Days on Markers of NLRP3 Activation in Healthy Humans
    Helena Neudorf, Garett S. Jackson, Jonathan P. Little · 2022 · Journal of Nutrition and Metabolism
  55. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update
    Sonia Kaur Singh, Shiwangi Sharma, Himanshu Sharma · 2024 · Current Pharmaceutical Biotechnology
  56. Bone and Energy Metabolism
    Clifford james Rosen · 2017 · Molecular and integrative toxicology
  57. Gut Microbes: The Miniscule Laborers in the Human Body
    Suma Sarojini · 2018 · Elsevier eBooks
  58. Omentin and Apelin Concentrations in Relation to Obesity Diabetes Mellitus Type two and Cardiovascular Diseases in Egyptiant Population
    Sherine M. Ibrahim · 2015 · Endocrinology&Metabolism International Journal
  59. Structural insights of sulfonamide-based NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization
    Yiming Xu, Matteo Scipioni, Hallie Blevins, Shijun Zhang · 2021 · Medicinal Chemistry Research
  60. Cytokines: Pulling the Body Together as a Whole
    Giamila Fantuzzi · 2011 · The Scientific World JOURNAL
  61. Glyburide Accelerates the Process of Tendon Healing by Inhibiting NLRP3 Inflammasome in Calcific Tendinopathy
    WeiYi Chen, WanQing Qi, MengYang Jia, QianRu Yao, Ying Yang, YunQing Su, Xianxiang Xiang · 2025 · The American Journal of Sports Medicine
  62. Crosstalk between NLRP3 Signaling and Histone Deacetylases in Inflammasome-Driven Diseases
    Kathrin Tan, M. Mercedes Rodríguez-Fernández, Tim Keuler, Finn K. Hansen, Michael Gütschow, Günther Weindl, Jose Luis Marco · 2025 · Journal of Medicinal Chemistry
  63. Adiponectin in neuroinflammation and parkinson’s disease: A macromolecular and therapeutic perspective
    Kanupriya Chauhan, Mayur Porwal, Shamsher Singh · 2026 · Metabolic Brain Disease
  64. The NLRP3 inflammasome in metabolic dysfunction-associated steatotic liver disease: role and advances in therapeutic targeting
    Sheng Wei, Yanlang He, Chen Luo, Xiaofeng He · 2026 · Frontiers in Immunology
  65. The Role of Inflammation in Type 2 Diabetes-Driven Atherosclerosis
    Jennifer Emily Enns, Carla G. Taylor, Peter C. Zahradka · 2013 · Springer eBooks
  66. Nucleotide-Binding Oligomerization Domain-Like Receptor 3 Inflammasome Inhibition by MCC950 Reduces the Lipopolysaccharide-Induced Interleukin-1β in Cultured Dispersed Nasal Polyp Cells
    Soo Kyoung Park, Ruining Han, Jun Xu, Sun Hee Yeon, Sung Bok Lee, Kun‐Ho Song, Jenny Byun, Ki‐Sang Rha, Yong Min Kim · 2020 · Korean Journal of Otorhinolaryngology - Head and Neck Surgery
  67. Targeting O-GlcNAcylation in tumor-associated inflammation: From molecular mechanisms to cancer therapy
    Rui Shi, Ling Gao, Shaoming Li, Wenhao Ren, Keqian Zhi · 2025 · Critical Reviews in Oncology/Hematology
  68. Recent Advances in Obesity Research and Management
    Dae Ho Lee · 2012 · Hanyang Medical Reviews
  69. Essential Oil from the Heartwood of Taiwan fir Ameliorates LPS-induced Inflammatory Response by Inhibiting the Activation of Mitogen-activated Protein Kinase
    May-Lan Liu, Kuo‐Feng Hua, Tzu-Jung Yang, Huan-Wen Chiu, Chen‐Lung Ho · 2014 · Natural Product Communications
  70. Plasticizer dibutyl phthalate impairs vascular endothelial function
    Zihui Zhang, XinYa XIE, Fan Li, NanPing WANG, Lei XIAO · 2018 · Scientia Sinica Vitae
  71. Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs)
    Walter Gottlieb Land · 2018 · Springer eBooks
  72. Cardiac Inflammasome and Arrhythmia
    Na Li, Dobromir Dobrev · 2022 · Springer eBooks
  73. Chemical constituents from Vitex negundo var. cannabifolia (Sieb. et Zucc.) Hand.-Mazz. (Lamiaceae) and their chemotaxonomic significance
    Muhammad Aurang Zeb, Peng‐Yun Yang, De‐Wen Bi, Wen‐Chao Tu, Xiaoli Li, Ruihan Zhang, Xing‐Jie Zhang, Wei‐Lie Xiao · 2023 · Biochemical Systematics and Ecology
  74. Inflammasomes and Autoinflammation
    Lori Broderick · 2019 · Springer eBooks
  75. Comparative efficacy of febuxostat and vitamin E in the management of MASLD: Insights from a randomized parallel clinical study
    Hadier M. El-sheikh, Sahar M. El-Haggar, Rehab Badawi, Eslam Habba · 2025 · European Journal of Pharmacology
  76. The Statin Floor Effect: a Mechanistic Framework for Residual Cardiovascular Risk
    Evan J. Peacock · 2026 · Cardiovascular Drugs and Therapy
  77. Mechanistic understanding of the protective effects of baicalein against the inflammatory response induced by Toxoplasma gondii in Ana-1 macrophages
    XiaoJuan Wang, Zhengqing Yu, WeiYu Qi, YuChen Jiang, Pinglong Yang, JiuSu Tu, YunNan Fang, Pan Zhou, Li Zhang · 2026 · Molecular Immunology
  78. Extrapulmonary distribution, organ effect of nanosilica and micro-silica in C57BL/6J mouse intratracheal instillation model
    Guo Chen, Aoxiang Hu, Ting Liu, Tinghua Yan, Xiya Li, Shi Chen · 2026 · Ecotoxicology and Environmental Safety
  79. Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome
    Naranjan S. Dhalla, Chigar A. Patel, Jayesh Beladiya, Anita A. Mehta, Tejal Ricky Gandhi · 2026 · Journal of Molecular and Cellular Cardiology
  80. NLRP3 Inflammasome Activation and Atherogenic Lipid Profile in Hemodialysis Patients
    Mohammed .N. Abdelaziz, Nehal Atef Elshabrawy, Ahmed Saad Almenshawy, Karim A. Elsodany, Hager G. El-kasabi, Ahmed A. Hammad, Hana H. Attia, Khaled Mokhtar, Radwa ElSayed, Emad Samaan · 2026 · Therapeutic Apheresis and Dialysis
  81. Potential Therapeutic Natural Products for the Treatment of Obesity-Associated Chronic Inflammation by Targeting TLRs and Inflammasomes
    Yoshinori Nagai, Hiroe Honda, Yasuharu Watanabe, Kiyoshi Takatsu · 2016 · Springer eBooks
  82. The Immune System and Inflammation in Type 2 Diabetes
    Rebeca García Macedo · 2019 · Springer eBooks
  83. Changing phenotype of inflammatory bowel disease and neglected metabolic health
    John O’Grady, Fergus Shanahan · 2021 · Cogent Medicine
  84. Cafeteria diet-induced obesity remodels immune response in acute Trypanosoma cruzi infection
    Amanda Goulart, Naira Ferreira Anchieta, Pedro Alexandre Sampaio, Vânia Brazão, Jefferson Luiz da Silva, Gisele Bulhões Portapilla, Andressa Duarte, Daiane Y. Tezuka, Maiara Voltarelli Providello, Angelita Maria Stabile et al. · 2023 · Immunobiology
  85. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature
    Sweatha Mani, Abirami Balasubramanian, Keerthana Veluswami, Sudipta Rao, Shailesh Aggarwal · 2024 · Cureus
  86. Pattern Recognition Receptors and Aging
    Karim Hamdy Shalaby · 2013 · Springer eBooks
  87. NLRP3 inflammasome: A therapeutic option for kidney disease?
    Neudo Buelvas, Raibel Janis Suárez Useche, José Ramón Vielma Guevara · 2017 · Revista de Salud Pública
  88. The Regulatory Mechanism of NLRP3 Inflammasome in Oral Squamous Cell Carcinoma
    倩钰 程 · 2024 · Advances in Clinical Medicine
  89. MAbs Targeting Soluble Mediators in Phase 1 and 2 Clinical Studies Immunological Disorders
    Frank R. Brennan · 2014 · Wiley eBooks
  90. Innate immune modulation in atherosclerosis - with focus on ApoB100 derived danger associated signal 1 (ApoBDS-1)
    Yajuan Wang · 2014 · Figshare
  91. Editorial: Lipids: fueling the fire in tuberculosis?
    Vishwa Deep Dixit · 2012 · Journal of Leukocyte Biology
  92. Roles in innate immune receptors: Host : pathogen interactions and strengthening vaccines
    Sanna Nyström · 2013 · Figshare
  93. Analysis of Tandem Repeat Patterns in Nlrc4 using a Motif Model
    Sim-Hui Tee · 2012 · International Journal of Information Technology and Computer Science
  94. Macrophage Activation and Differentiation with Cholesterol Crystals
    Hannah Mahony Burrowes · 2012 · UC Research Repository (University of Canterbury)
  95. Use of Zebrafish As a Model for Understanding the Interplay Between Inflammation and Stem Cells
    Çağhan Kızıl · 2014 · Turkish Journal of Immunology
  96. Perinatal programming of metabolic dysfunction and obesity-induced inflammation
    Camilla Ingvorsen, Lars Ingvar Hellgren, Susanne Brix · 2013
  97. Efeitos dos ácidos graxos na função de macrófagos de camundongos com diabetes tipo I induzido.
    Mariana Rodrigues Davanso Braga · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  98. Role of NLRP3 Inflammasomes in Obesity-Induced Cardiovascular Diseases
    Krishna Murthy Boini, Pin‐Lan Li, Saisudha Koka · 2020 · Springer eBooks
  99. Bioactive lipids in immune cells function and immune disorders
    Asim K. Duttaroy · 2021 · Elsevier eBooks
  100. Leptin Signalling in the Ovary of Diet-Induced Obese Mice Regulates Activation of Nod-Like Receptor Protein 3 Inflammasome
    Marek Adamowski, Karolina Wołodko, Joana Oliveira, Juan Castillo Fernandez, Daniel Murta, Gavin Kelsey, António Miguel Galvão · 2021 · bioRxiv (Cold Spring Harbor Laboratory)